Medical Dermatology Therapy Update IV
Medical dermatologic conditions include autoimmune, malignant, or chronic inflammatory diseases that range in severity from skin-localized involvement to life-threatening, multi-organ, systemic involvement. Many of these medical dermatologic diseases are challenging to treat, and patients with them may require collaboration between specialists across several disciplines for adequate management. Given that nearly one in three adults is affected by a skin disease, education that improves medical dermatologic care has the potential to improve outcomes in a substantial patient population. During the past decade, research has refined and optimized the use of traditional treatments for many medical dermatologic diseases. As a result, there has been an explosion in the development of biologic and small-molecule therapeutic agents for dermatologic diseases.
By Participating, You Will Be Able To:
- Evaluate and apply current evidence-based and emerging medical therapies for rheumatology/dermatology overlap diseases, including cutaneous vasculitis, fibrosing skin diseases, cutaneous lupus erythematosus, and dermatomyositis.
- Discuss “hot topics” related to medical dermatology therapies, including CAR-T therapy, direct immunofluorescence evaluation, and cosmetic procedures in patients with rheum/derm overlap diseases.
- Apply current evidence-based and emerging therapies for acne vulgaris and hidradenitis suppurativa to personalize treatment selection and improve disease control.
- Apply current and emerging evidence-based therapies to optimize management of chronic urticaria, atopic dermatitis, and prurigo nodularis, tailoring treatment to disease severity, symptom burden, and safety considerations.
- Integrate emerging insights on skin resident memory T-cells with current and evolving treatment strategies to optimize diagnosis and management of the skin, joint, and systemic manifestations of psoriasis vulgaris, psoriatic arthritis, and cutaneous T-cell lymphomas.
- Critically appraise and apply contemporary and emerging medical therapies for complex medical dermatologic diseases, including advanced non-melanoma skin cancer, advanced melanoma, autoimmune bullous diseases, sarcoidosis and other granulomatous diseases, vitiligo, inflammatory alopecia disorders, and newly recognized infectious diseases in medical dermatology.
Who Should Attend?
These activities are designed for a primary audience of physicians including dermatologists, rheumatologists, oncologists, internal medicine, immunology, nurses, nurse practitioners, pharmacists, physician assistants, residents, and fellows.